Skip to main content
. 2018 Jul 10;29(2):1032–1038. doi: 10.1007/s00330-018-5618-5

Table 4.

Cox regression model for adjusted hazard ratios (HRs) for the association of target tumour enhancement at 20-min delayed phase imaging (Target TuEn20) on gadoxetate-enhanced MRI and overall survival (n = 62)

Adjusted hazard ratio (95% confidence interval) p value
Low TuEn 20
 Weak Reference p = 0.018*
 Strong 0.32 (0.12-0.82)
Clinical risk score
 < 3 Reference p = 0.019*
 ≥ 3 3.20 (1.21-8.45)

*p < 0.05